Fredrik Sund

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological response.

Adverse drug reactions following SARS-CoV-2 vaccination of 3805 healthcare workers cause substantial sick-leave and are correlated to vaccine regimen, age, sex and serological response.

Journal: Vaccine

Published: November 08, 2024

Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Journal: British journal of haematology

Published: January 07, 2022

Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.

Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.

Journal: Upsala journal of medical sciences

Published: July 21, 2020

Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.

Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: May 14, 2020

Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.

Clinical significance of IgM and IgA class anti-NMDAR antibodies in herpes simplex encephalitis.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: March 16, 2018

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial.

Journal: Lancet (London, England)

Published: December 04, 2014

Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.

Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: December 18, 2012

Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.

Cytomegalovirus-specific CD4 and CD8 T cell responses in infants and children.

Journal: Scandinavian journal of immunology

Published: July 15, 2012

CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.

CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.

Journal: Clinical transplantation

Published: February 19, 2009

Showing 1-9 of 9

Last Updated: 09/26/2026